Original document(47 pages)  中文版
    The present invention relates to A composition obtained from the lipid soluble extract of rhizomes and leaves of Curcuma species of Zingiberaceae family, useful for the treatment of neurocerebrovascular disorders, said composition comprising fraction A consisting of arturmerone of formula (1), and turmerone of formula (2), and/or along with fraction B consisting of curcumene and zingiberine, and/or fraction C consisting of germacrone, curcumerone, zedoarone, sedoarondiol, isozdedoaronidiol, curcumenone, and curlone, and/or pharmaceutically acceptable additives and a method of treating neurocerebrovascular disorders in animals including humans using said composition by administering therapeutically effective amount of lipid soluble extract.
Application Number
申请号		 02827077 Application Date
申请日		 2002.12.14
Title 名称 A composition for treating neurocerebrovascular disorders
Publication Number
公开号		 1615144 Publication Date
公开日		 2005.05.11
Approval Pub. Date Granted Pub. Date
International Classification 分类号 A61K35/78;A61K31/12;A61K31/121;C07C49/203;C07C49/647
Applicant(s) Name
申请人		 Council Scient Ind Res
Address 地址
Inventor(s) Name 发明人 Ray Madhur;Pal Ragavendra;Singh Satyawan;Khanna Nandoo Man
Attorney & Agent 代理人 tang xiaofeng

  
Lower alcohol-insoluble extract of hovenia dulcis thunb and a polysaccharide isolated therefrom
Ginger extract preparation
Treatment of glioblastoma with thymosin-alpha 1
Methods and compositions for derepression of IAP-inhibited caspase
Drug mobilizing pluripotent stem cells from tissue into peripheral blood
Assay for the detection of factors that modulate the expression of INGAP
Plasmid mediated suplementation for treating chronically ill subjects
Method for reducing acne or improving skin tone
Drug for preventing vascular restenosis and instrument to be embedded in vessel coated with the drug
Oral administration of interferon-TAU
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.